4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008432
Options or other derivatives
- Chief Financial Officer acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008432
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…